[
  {
    "title": "A Look at Pharma ETFs Post Q1 Earnings",
    "published": 1715095800,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 43.97999954223633,
      "2024-05-07T14:30:00+00:00": 44.064998626708984,
      "2024-05-07T15:30:00+00:00": 44.029998779296875,
      "2024-05-07T16:30:00+00:00": 44.1781005859375,
      "2024-05-07T17:30:00+00:00": 44.099998474121094,
      "2024-05-07T18:30:00+00:00": 43.93000030517578,
      "2024-05-07T19:30:00+00:00": 43.900001525878906
    },
    "sentiment": 0.9325221180915833
  },
  {
    "title": "Bristol Myers Squibb to Participate in Upcoming Investor Conferences",
    "published": 1715079540,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 43.97999954223633,
      "2024-05-07T14:30:00+00:00": 44.064998626708984,
      "2024-05-07T15:30:00+00:00": 44.029998779296875,
      "2024-05-07T16:30:00+00:00": 44.1781005859375,
      "2024-05-07T17:30:00+00:00": 44.099998474121094,
      "2024-05-07T18:30:00+00:00": 43.93000030517578,
      "2024-05-07T19:30:00+00:00": 43.900001525878906
    },
    "sentiment": 0.89532470703125
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Lyra Therapeutics (LYRA), Bristol-Myers Squibb (BMY) and Axsome Therapeutics (AXSM)",
    "published": 1715055840,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 43.97999954223633,
      "2024-05-07T14:30:00+00:00": 44.064998626708984,
      "2024-05-07T15:30:00+00:00": 44.029998779296875,
      "2024-05-07T16:30:00+00:00": 44.1781005859375,
      "2024-05-07T17:30:00+00:00": 44.099998474121094,
      "2024-05-07T18:30:00+00:00": 43.93000030517578,
      "2024-05-07T19:30:00+00:00": 43.900001525878906
    },
    "sentiment": 0.9137399792671204
  },
  {
    "title": "FDA accepts Bristol Myers application for injected Opdivo",
    "published": 1714994100,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 44.15999984741211,
      "2024-05-06T14:30:00+00:00": 44.22999954223633,
      "2024-05-06T15:30:00+00:00": 44.005001068115234,
      "2024-05-06T16:30:00+00:00": 44.0088996887207,
      "2024-05-06T17:30:00+00:00": 43.99020004272461,
      "2024-05-06T18:30:00+00:00": 44.040000915527344,
      "2024-05-06T19:30:00+00:00": 43.80690002441406
    },
    "sentiment": 0.5047883987426758
  },
  {
    "title": "U.S. Food and Drug Administration Accepts Bristol Myers Squibb\u2019s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)",
    "published": 1714993140,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 44.15999984741211,
      "2024-05-06T14:30:00+00:00": 44.22999954223633,
      "2024-05-06T15:30:00+00:00": 44.005001068115234,
      "2024-05-06T16:30:00+00:00": 44.0088996887207,
      "2024-05-06T17:30:00+00:00": 43.99020004272461,
      "2024-05-06T18:30:00+00:00": 44.040000915527344,
      "2024-05-06T19:30:00+00:00": 43.80690002441406
    },
    "sentiment": 0.8978764414787292
  },
  {
    "title": "Bristol-Myers Gets FDA Acceptance of Review for Subcutaneous Opdivo Formulation",
    "published": 1714981896,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 44.15999984741211,
      "2024-05-06T14:30:00+00:00": 44.22999954223633,
      "2024-05-06T15:30:00+00:00": 44.005001068115234,
      "2024-05-06T16:30:00+00:00": 44.0088996887207,
      "2024-05-06T17:30:00+00:00": 43.99020004272461,
      "2024-05-06T18:30:00+00:00": 44.040000915527344,
      "2024-05-06T19:30:00+00:00": 43.80690002441406
    },
    "sentiment": 0.927141010761261
  },
  {
    "title": "Bristol Myers' application for Opdivo plus Yervoy validated by EMA",
    "published": 1714975500,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 44.15999984741211,
      "2024-05-06T14:30:00+00:00": 44.22999954223633,
      "2024-05-06T15:30:00+00:00": 44.005001068115234,
      "2024-05-06T16:30:00+00:00": 44.0088996887207,
      "2024-05-06T17:30:00+00:00": 43.99020004272461,
      "2024-05-06T18:30:00+00:00": 44.040000915527344,
      "2024-05-06T19:30:00+00:00": 43.80690002441406
    },
    "sentiment": 0.9060776233673096
  },
  {
    "title": "Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago",
    "published": 1714820480,
    "day_prices": {},
    "sentiment": 0.9702085256576538
  },
  {
    "title": "Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?",
    "published": 1714743000,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 43.959999084472656,
      "2024-05-03T14:30:00+00:00": 44.04999923706055,
      "2024-05-03T15:30:00+00:00": 43.91999816894531,
      "2024-05-03T16:30:00+00:00": 43.94499969482422,
      "2024-05-03T17:30:00+00:00": 43.790000915527344,
      "2024-05-03T18:30:00+00:00": 43.849998474121094,
      "2024-05-03T19:30:00+00:00": 43.849998474121094
    },
    "sentiment": 0.915772020816803
  },
  {
    "title": "If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today",
    "published": 1714734900,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 43.959999084472656,
      "2024-05-03T14:30:00+00:00": 44.04999923706055,
      "2024-05-03T15:30:00+00:00": 43.91999816894531,
      "2024-05-03T16:30:00+00:00": 43.94499969482422,
      "2024-05-03T17:30:00+00:00": 43.790000915527344,
      "2024-05-03T18:30:00+00:00": 43.849998474121094,
      "2024-05-03T19:30:00+00:00": 43.849998474121094
    },
    "sentiment": 0.9371642470359802
  },
  {
    "title": "The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine",
    "published": 1714727280,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 43.959999084472656,
      "2024-05-03T14:30:00+00:00": 44.04999923706055,
      "2024-05-03T15:30:00+00:00": 43.91999816894531,
      "2024-05-03T16:30:00+00:00": 43.94499969482422,
      "2024-05-03T17:30:00+00:00": 43.790000915527344,
      "2024-05-03T18:30:00+00:00": 43.849998474121094,
      "2024-05-03T19:30:00+00:00": 43.849998474121094
    },
    "sentiment": 0.94817054271698
  },
  {
    "title": "Bristol-Myers Squibb: A Lost Decade?",
    "published": 1714683666,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 44.36000061035156,
      "2024-05-02T14:30:00+00:00": 43.7599983215332,
      "2024-05-02T15:30:00+00:00": 43.92499923706055,
      "2024-05-02T16:30:00+00:00": 44.0,
      "2024-05-02T17:30:00+00:00": 43.939998626708984,
      "2024-05-02T18:30:00+00:00": 43.83000183105469,
      "2024-05-02T19:30:00+00:00": 43.790000915527344
    },
    "sentiment": 0.5306175947189331
  },
  {
    "title": "Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More",
    "published": 1714658520,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 44.36000061035156,
      "2024-05-02T14:30:00+00:00": 43.7599983215332,
      "2024-05-02T15:30:00+00:00": 43.92499923706055,
      "2024-05-02T16:30:00+00:00": 44.0,
      "2024-05-02T17:30:00+00:00": 43.939998626708984,
      "2024-05-02T18:30:00+00:00": 43.83000183105469,
      "2024-05-02T19:30:00+00:00": 43.790000915527344
    },
    "sentiment": 0.6145809292793274
  },
  {
    "title": "3 Blue-Chip Bargains Trading At 52-Week Lows",
    "published": 1714633200,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 44.36000061035156,
      "2024-05-02T14:30:00+00:00": 43.7599983215332,
      "2024-05-02T15:30:00+00:00": 43.92499923706055,
      "2024-05-02T16:30:00+00:00": 44.0,
      "2024-05-02T17:30:00+00:00": 43.939998626708984,
      "2024-05-02T18:30:00+00:00": 43.83000183105469,
      "2024-05-02T19:30:00+00:00": 43.790000915527344
    },
    "sentiment": 0.9381420016288757
  },
  {
    "title": "Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration",
    "published": 1714564800,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 43.970001220703125,
      "2024-05-01T14:30:00+00:00": 44.119998931884766,
      "2024-05-01T15:30:00+00:00": 44.165000915527344,
      "2024-05-01T16:30:00+00:00": 44.189998626708984,
      "2024-05-01T17:30:00+00:00": 44.1349983215332,
      "2024-05-01T18:30:00+00:00": 44.01499938964844,
      "2024-05-01T19:30:00+00:00": 44.290000915527344
    },
    "sentiment": 0.8614452481269836
  },
  {
    "title": "Editas Medicine, Bristol Myers extend alpha-beta T cell collaboration",
    "published": 1714547940,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 43.970001220703125,
      "2024-05-01T14:30:00+00:00": 44.119998931884766,
      "2024-05-01T15:30:00+00:00": 44.165000915527344,
      "2024-05-01T16:30:00+00:00": 44.189998626708984,
      "2024-05-01T17:30:00+00:00": 44.1349983215332,
      "2024-05-01T18:30:00+00:00": 44.01499938964844,
      "2024-05-01T19:30:00+00:00": 44.290000915527344
    },
    "sentiment": 0.8017661571502686
  },
  {
    "title": "Hold Rating on Bristol-Myers Squibb Amid Earnings Uncertainty and Strategic Investments",
    "published": 1714541880,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 43.970001220703125,
      "2024-05-01T14:30:00+00:00": 44.119998931884766,
      "2024-05-01T15:30:00+00:00": 44.165000915527344,
      "2024-05-01T16:30:00+00:00": 44.189998626708984,
      "2024-05-01T17:30:00+00:00": 44.1349983215332,
      "2024-05-01T18:30:00+00:00": 44.01499938964844,
      "2024-05-01T19:30:00+00:00": 44.290000915527344
    },
    "sentiment": 0.8670029640197754
  },
  {
    "title": "Bristol Myers Squibb\u2019s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma",
    "published": 1715806685,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 45.0,
      "2024-05-15T14:30:00+00:00": 44.790000915527344,
      "2024-05-15T15:30:00+00:00": 44.79840087890625,
      "2024-05-15T16:30:00+00:00": 44.755001068115234,
      "2024-05-15T17:30:00+00:00": 44.72999954223633,
      "2024-05-15T18:30:00+00:00": 44.6150016784668,
      "2024-05-15T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.8672182559967041
  },
  {
    "title": "US FDA approves expanded use of Bristol's cancer cell therapy",
    "published": 1715792156,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 45.0,
      "2024-05-15T14:30:00+00:00": 44.790000915527344,
      "2024-05-15T15:30:00+00:00": 44.79840087890625,
      "2024-05-15T16:30:00+00:00": 44.755001068115234,
      "2024-05-15T17:30:00+00:00": 44.72999954223633,
      "2024-05-15T18:30:00+00:00": 44.6150016784668,
      "2024-05-15T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.7745218276977539
  },
  {
    "title": "Bristol Myers' Breyanzi CAR-T therapy approved by FDA in follicular lymphoma",
    "published": 1715760000,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 45.0,
      "2024-05-15T14:30:00+00:00": 44.790000915527344,
      "2024-05-15T15:30:00+00:00": 44.79840087890625,
      "2024-05-15T16:30:00+00:00": 44.755001068115234,
      "2024-05-15T17:30:00+00:00": 44.72999954223633,
      "2024-05-15T18:30:00+00:00": 44.6150016784668,
      "2024-05-15T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.8509728908538818
  },
  {
    "title": "Bristol Myers' Breyanzi gains additional indication for follicular lymphoma",
    "published": 1715748120,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 45.0,
      "2024-05-15T14:30:00+00:00": 44.790000915527344,
      "2024-05-15T15:30:00+00:00": 44.79840087890625,
      "2024-05-15T16:30:00+00:00": 44.755001068115234,
      "2024-05-15T17:30:00+00:00": 44.72999954223633,
      "2024-05-15T18:30:00+00:00": 44.6150016784668,
      "2024-05-15T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.9256910085678101
  },
  {
    "title": "Dividend Capture Captains: The 3 Best Blue-Chip Stocks for Tactical Traders",
    "published": 1715683560,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 45.380001068115234,
      "2024-05-14T14:30:00+00:00": 44.8849983215332,
      "2024-05-14T15:30:00+00:00": 44.7400016784668,
      "2024-05-14T16:30:00+00:00": 44.64500045776367,
      "2024-05-14T17:30:00+00:00": 44.56999969482422,
      "2024-05-14T18:30:00+00:00": 44.61000061035156,
      "2024-05-14T19:30:00+00:00": 44.8849983215332
    },
    "sentiment": 0.8380469679832458
  },
  {
    "title": "Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug",
    "published": 1715662879,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 45.380001068115234,
      "2024-05-14T14:30:00+00:00": 44.8849983215332,
      "2024-05-14T15:30:00+00:00": 44.7400016784668,
      "2024-05-14T16:30:00+00:00": 44.64500045776367,
      "2024-05-14T17:30:00+00:00": 44.56999969482422,
      "2024-05-14T18:30:00+00:00": 44.61000061035156,
      "2024-05-14T19:30:00+00:00": 44.8849983215332
    },
    "sentiment": 0.5977020263671875
  },
  {
    "title": "One stock is dragging down the S&P 500's earnings growth",
    "published": 1715618473,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 44.880001068115234,
      "2024-05-13T14:30:00+00:00": 45.20000076293945,
      "2024-05-13T15:30:00+00:00": 45.13999938964844,
      "2024-05-13T16:30:00+00:00": 45.125,
      "2024-05-13T17:30:00+00:00": 45.064998626708984,
      "2024-05-13T18:30:00+00:00": 45.084999084472656,
      "2024-05-13T19:30:00+00:00": 44.92499923706055
    },
    "sentiment": 0.9579587578773499
  },
  {
    "title": "Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study",
    "published": 1715613360,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 44.880001068115234,
      "2024-05-13T14:30:00+00:00": 45.20000076293945,
      "2024-05-13T15:30:00+00:00": 45.13999938964844,
      "2024-05-13T16:30:00+00:00": 45.125,
      "2024-05-13T17:30:00+00:00": 45.064998626708984,
      "2024-05-13T18:30:00+00:00": 45.084999084472656,
      "2024-05-13T19:30:00+00:00": 44.92499923706055
    },
    "sentiment": 0.9585000872612
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)",
    "published": 1715610188,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 44.880001068115234,
      "2024-05-13T14:30:00+00:00": 45.20000076293945,
      "2024-05-13T15:30:00+00:00": 45.13999938964844,
      "2024-05-13T16:30:00+00:00": 45.125,
      "2024-05-13T17:30:00+00:00": 45.064998626708984,
      "2024-05-13T18:30:00+00:00": 45.084999084472656,
      "2024-05-13T19:30:00+00:00": 44.92499923706055
    },
    "sentiment": 0.9365403652191162
  },
  {
    "title": "Merck discontinues testing of experimental skin cancer combo therapy",
    "published": 1715583840,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 44.880001068115234,
      "2024-05-13T14:30:00+00:00": 45.20000076293945,
      "2024-05-13T15:30:00+00:00": 45.13999938964844,
      "2024-05-13T16:30:00+00:00": 45.125,
      "2024-05-13T17:30:00+00:00": 45.064998626708984,
      "2024-05-13T18:30:00+00:00": 45.084999084472656,
      "2024-05-13T19:30:00+00:00": 44.92499923706055
    },
    "sentiment": 0.9100384712219238
  },
  {
    "title": "Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip",
    "published": 1715503500,
    "day_prices": {},
    "sentiment": 0.8015245199203491
  },
  {
    "title": "Organon Graduates From Spinoff\u00a0Skepticism, With A Yield Above 5%",
    "published": 1715410713,
    "day_prices": {},
    "sentiment": 0.7050560712814331
  },
  {
    "title": "Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial",
    "published": 1715373000,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 44.75,
      "2024-05-10T14:30:00+00:00": 44.82500076293945,
      "2024-05-10T15:30:00+00:00": 44.685001373291016,
      "2024-05-10T16:30:00+00:00": 44.709999084472656,
      "2024-05-10T17:30:00+00:00": 44.790000915527344,
      "2024-05-10T18:30:00+00:00": 44.69430160522461,
      "2024-05-10T19:30:00+00:00": 44.83000183105469
    },
    "sentiment": 0.9249863624572754
  },
  {
    "title": "Success Rate as High as 90% for AI-Discovered Drugs",
    "published": 1715317500,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 44.75,
      "2024-05-10T14:30:00+00:00": 44.82500076293945,
      "2024-05-10T15:30:00+00:00": 44.685001373291016,
      "2024-05-10T16:30:00+00:00": 44.709999084472656,
      "2024-05-10T17:30:00+00:00": 44.790000915527344,
      "2024-05-10T18:30:00+00:00": 44.69430160522461,
      "2024-05-10T19:30:00+00:00": 44.83000183105469
    },
    "sentiment": 0.8889439702033997
  },
  {
    "title": "Bristol Myers announces CheckMate -73L trial did not meet primary endpoint",
    "published": 1715311920,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 44.75,
      "2024-05-10T14:30:00+00:00": 44.82500076293945,
      "2024-05-10T15:30:00+00:00": 44.685001373291016,
      "2024-05-10T16:30:00+00:00": 44.709999084472656,
      "2024-05-10T17:30:00+00:00": 44.790000915527344,
      "2024-05-10T18:30:00+00:00": 44.69430160522461,
      "2024-05-10T19:30:00+00:00": 44.83000183105469
    },
    "sentiment": 0.8478593230247498
  },
  {
    "title": "Moat Stocks React To Inflation And Slowing Growth",
    "published": 1715253000,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 43.560001373291016,
      "2024-05-09T14:30:00+00:00": 43.900001525878906,
      "2024-05-09T15:30:00+00:00": 43.880001068115234,
      "2024-05-09T16:30:00+00:00": 43.86000061035156,
      "2024-05-09T17:30:00+00:00": 44.064998626708984,
      "2024-05-09T18:30:00+00:00": 44.28499984741211,
      "2024-05-09T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.42709460854530334
  },
  {
    "title": "Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution",
    "published": 1715166012,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 44.0,
      "2024-05-08T14:30:00+00:00": 43.810001373291016,
      "2024-05-08T15:30:00+00:00": 43.73500061035156,
      "2024-05-08T16:30:00+00:00": 43.709999084472656,
      "2024-05-08T17:30:00+00:00": 43.58000183105469,
      "2024-05-08T18:30:00+00:00": 43.73500061035156,
      "2024-05-08T19:30:00+00:00": 43.654998779296875
    },
    "sentiment": 0.6394791603088379
  },
  {
    "title": "Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?",
    "published": 1716469219,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.7013425827026367
  },
  {
    "title": "Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus",
    "published": 1716467812,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.8098769187927246
  },
  {
    "title": "Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting",
    "published": 1716461940,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.9381774663925171
  },
  {
    "title": "Bristol-Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity",
    "published": 1716454740,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.9280712008476257
  },
  {
    "title": "SMALL-CAP WINNERS & LOSERS: Capital & Regional gets takeover offer",
    "published": 1716440940,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.9419151544570923
  },
  {
    "title": "LONDON MARKET OPEN: National Grid drags FTSE 100 lower",
    "published": 1716437040,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.9537860155105591
  },
  {
    "title": "Bloomsbury Publishing Announces New Chairman",
    "published": 1716430080,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.8524619936943054
  },
  {
    "title": "Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M",
    "published": 1716405912,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.9097902178764343
  },
  {
    "title": "Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo",
    "published": 1716398040,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.8350327610969543
  },
  {
    "title": "Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million",
    "published": 1716393962,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.8466559648513794
  },
  {
    "title": "Bristol-Myers Squibb Announces Strategies to Improve Access to Medicines",
    "published": 1716379063,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.7279292941093445
  },
  {
    "title": "Bristol Myers: 10-year strategy for poor countries",
    "published": 1716363416,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.8093820810317993
  },
  {
    "title": "Bristol Myers announces strategy to reach low- and middle-income countries",
    "published": 1716357720,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.5341288447380066
  },
  {
    "title": "Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit",
    "published": 1716352124,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.9458606243133545
  },
  {
    "title": "Bristol-Myers Squibb snaps six days of losses, trades in the green",
    "published": 1716348360,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.8081240653991699
  },
  {
    "title": "Bristol Myers, Sanofi liability in Hawaii Plavix litigation tops $900M",
    "published": 1716345600,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.7823261022567749
  },
  {
    "title": "1 Stock I Wouldn't Touch With a 10-Foot Pole",
    "published": 1716293700,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.9282525181770325
  },
  {
    "title": "Bristol Myers: national schizophrenia campaign",
    "published": 1716289962,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.9165869355201721
  },
  {
    "title": "Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity",
    "published": 1716288480,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.8404976725578308
  },
  {
    "title": "Interesting BMY Put And Call Options For March 2025",
    "published": 1716284160,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.9389216899871826
  },
  {
    "title": "UK earnings, trading statements calendar - next 21 days",
    "published": 1716281940,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.8611915707588196
  },
  {
    "title": "Bristol-Myers says FDA has revised decision date on injected Opdivo",
    "published": 1716273120,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.5019626617431641
  },
  {
    "title": "Bristol Myers announces updated action date by FDA for nivolumab",
    "published": 1716271320,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.9115890860557556
  },
  {
    "title": "November 15th Options Now Available For Bristol Myers Squibb (BMY)",
    "published": 1716198180,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 44.0,
      "2024-05-20T14:30:00+00:00": 43.948699951171875,
      "2024-05-20T15:30:00+00:00": 43.8650016784668,
      "2024-05-20T16:30:00+00:00": 43.724998474121094,
      "2024-05-20T17:30:00+00:00": 43.69499969482422,
      "2024-05-20T18:30:00+00:00": 43.654998779296875,
      "2024-05-20T19:30:00+00:00": 43.525001525878906
    },
    "sentiment": 0.9414032697677612
  },
  {
    "title": "SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?",
    "published": 1716084420,
    "day_prices": {},
    "sentiment": 0.8515270948410034
  },
  {
    "title": "Novo Nordisk, J&J lead R&D rankings in big pharma: report",
    "published": 1715997240,
    "day_prices": {},
    "sentiment": 0.8400076031684875
  },
  {
    "title": "May's 5 Dividend Growth Stocks With 5.49%+ Yields",
    "published": 1715954969,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 44.29999923706055,
      "2024-05-17T14:30:00+00:00": 43.83000183105469,
      "2024-05-17T15:30:00+00:00": 43.72999954223633,
      "2024-05-17T16:30:00+00:00": 43.810001373291016,
      "2024-05-17T17:30:00+00:00": 44.1349983215332,
      "2024-05-17T18:30:00+00:00": 44.14500045776367,
      "2024-05-17T19:30:00+00:00": 44.13050079345703
    },
    "sentiment": 0.48929792642593384
  },
  {
    "title": "The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers",
    "published": 1715947440,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 44.29999923706055,
      "2024-05-17T14:30:00+00:00": 43.83000183105469,
      "2024-05-17T15:30:00+00:00": 43.72999954223633,
      "2024-05-17T16:30:00+00:00": 43.810001373291016,
      "2024-05-17T17:30:00+00:00": 44.1349983215332,
      "2024-05-17T18:30:00+00:00": 44.14500045776367,
      "2024-05-17T19:30:00+00:00": 44.13050079345703
    },
    "sentiment": 0.944409966468811
  },
  {
    "title": "BMS reports four-year data from psoriasis treatment extension trial",
    "published": 1715935324,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 44.29999923706055,
      "2024-05-17T14:30:00+00:00": 43.83000183105469,
      "2024-05-17T15:30:00+00:00": 43.72999954223633,
      "2024-05-17T16:30:00+00:00": 43.810001373291016,
      "2024-05-17T17:30:00+00:00": 44.1349983215332,
      "2024-05-17T18:30:00+00:00": 44.14500045776367,
      "2024-05-17T19:30:00+00:00": 44.13050079345703
    },
    "sentiment": 0.7566370368003845
  },
  {
    "title": "Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY",
    "published": 1715877960,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.6718593239784241
  },
  {
    "title": "Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion",
    "published": 1715862900,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.661754846572876
  },
  {
    "title": "FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously Treated Follicular Lymphoma",
    "published": 1715857200,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.8431336283683777
  },
  {
    "title": "Bristol Myers reports new four-year Sotyktu data",
    "published": 1715851740,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.8657287955284119
  },
  {
    "title": "Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma",
    "published": 1715842175,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.854561984539032
  },
  {
    "title": "Walmart Earnings And The State Of The Consumer",
    "published": 1715836620,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.8318517208099365
  },
  {
    "title": "Novartis boasts Scemblix beats tyrosine kinase inhibitors for chronic myeloid leukemia",
    "published": 1717154640,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 40.25,
      "2024-05-31T14:30:00+00:00": 40.744998931884766,
      "2024-05-31T15:30:00+00:00": 40.845001220703125,
      "2024-05-31T16:30:00+00:00": 41.03499984741211,
      "2024-05-31T17:30:00+00:00": 40.968299865722656,
      "2024-05-31T18:30:00+00:00": 41.05500030517578,
      "2024-05-31T19:30:00+00:00": 40.945499420166016
    },
    "sentiment": 0.7673794031143188
  },
  {
    "title": "Bristol Myers' Breyanzi approved by FDA as new CAR T cell therapy in MCL",
    "published": 1717146060,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 40.25,
      "2024-05-31T14:30:00+00:00": 40.744998931884766,
      "2024-05-31T15:30:00+00:00": 40.845001220703125,
      "2024-05-31T16:30:00+00:00": 41.03499984741211,
      "2024-05-31T17:30:00+00:00": 40.968299865722656,
      "2024-05-31T18:30:00+00:00": 41.05500030517578,
      "2024-05-31T19:30:00+00:00": 40.945499420166016
    },
    "sentiment": 0.7982284426689148
  },
  {
    "title": "6% Yield Bristol Myers Squibb Value Trap Or Long-Term Opportunity?",
    "published": 1717128000,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 40.25,
      "2024-05-31T14:30:00+00:00": 40.744998931884766,
      "2024-05-31T15:30:00+00:00": 40.845001220703125,
      "2024-05-31T16:30:00+00:00": 41.03499984741211,
      "2024-05-31T17:30:00+00:00": 40.968299865722656,
      "2024-05-31T18:30:00+00:00": 41.05500030517578,
      "2024-05-31T19:30:00+00:00": 40.945499420166016
    },
    "sentiment": 0.9033723473548889
  },
  {
    "title": "Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion",
    "published": 1717085700,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 40.13999938964844,
      "2024-05-30T14:30:00+00:00": 40.25,
      "2024-05-30T15:30:00+00:00": 40.48780059814453,
      "2024-05-30T16:30:00+00:00": 40.37990188598633,
      "2024-05-30T17:30:00+00:00": 40.54499816894531,
      "2024-05-30T18:30:00+00:00": 40.43000030517578,
      "2024-05-30T19:30:00+00:00": 40.349998474121094
    },
    "sentiment": 0.6427467465400696
  },
  {
    "title": "Bristol Myers: FDA approval for Breyanzi",
    "published": 1717071738,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 40.13999938964844,
      "2024-05-30T14:30:00+00:00": 40.25,
      "2024-05-30T15:30:00+00:00": 40.48780059814453,
      "2024-05-30T16:30:00+00:00": 40.37990188598633,
      "2024-05-30T17:30:00+00:00": 40.54499816894531,
      "2024-05-30T18:30:00+00:00": 40.43000030517578,
      "2024-05-30T19:30:00+00:00": 40.349998474121094
    },
    "sentiment": 0.8121939301490784
  },
  {
    "title": "US FDA allows use of Bristol's cell therapy for rare blood cancer",
    "published": 1717070131,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 40.13999938964844,
      "2024-05-30T14:30:00+00:00": 40.25,
      "2024-05-30T15:30:00+00:00": 40.48780059814453,
      "2024-05-30T16:30:00+00:00": 40.37990188598633,
      "2024-05-30T17:30:00+00:00": 40.54499816894531,
      "2024-05-30T18:30:00+00:00": 40.43000030517578,
      "2024-05-30T19:30:00+00:00": 40.349998474121094
    },
    "sentiment": 0.8958755731582642
  },
  {
    "title": "Bristol Myers' Breyanzi gains additional indication for mantle cell lymphoma",
    "published": 1717068480,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 40.13999938964844,
      "2024-05-30T14:30:00+00:00": 40.25,
      "2024-05-30T15:30:00+00:00": 40.48780059814453,
      "2024-05-30T16:30:00+00:00": 40.37990188598633,
      "2024-05-30T17:30:00+00:00": 40.54499816894531,
      "2024-05-30T18:30:00+00:00": 40.43000030517578,
      "2024-05-30T19:30:00+00:00": 40.349998474121094
    },
    "sentiment": 0.8878174424171448
  },
  {
    "title": "Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2024 Update",
    "published": 1717016058,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.9409561157226562
  },
  {
    "title": "BMS secures another EC approval for Opdivo combination",
    "published": 1716989215,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.9128811359405518
  },
  {
    "title": "Bristol-Myers receives Opdivo drug approval in Europe",
    "published": 1716986040,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.8794797658920288
  },
  {
    "title": "Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare",
    "published": 1716976320,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.9108498096466064
  },
  {
    "title": "Bristol Myers: new EC approval for Opdivo",
    "published": 1716967597,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.8537294268608093
  },
  {
    "title": "Truist Financial Sticks to Their Buy Rating for Bristol-Myers Squibb (BMY)",
    "published": 1716965820,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.8393563628196716
  },
  {
    "title": "Bristol Myers Squibb (BMY) Shares Cross 6% Yield Mark",
    "published": 1716948900,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.7013039588928223
  },
  {
    "title": "ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries",
    "published": 1716905700,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 41.220001220703125,
      "2024-05-28T14:30:00+00:00": 40.898799896240234,
      "2024-05-28T15:30:00+00:00": 40.937400817871094,
      "2024-05-28T16:30:00+00:00": 40.79999923706055,
      "2024-05-28T17:30:00+00:00": 40.5974006652832,
      "2024-05-28T18:30:00+00:00": 40.529998779296875,
      "2024-05-28T19:30:00+00:00": 40.439998626708984
    },
    "sentiment": 0.7349245548248291
  },
  {
    "title": "10 Health Care Stocks With Whale Alerts In Today's Session",
    "published": 1716900120,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 41.220001220703125,
      "2024-05-28T14:30:00+00:00": 40.898799896240234,
      "2024-05-28T15:30:00+00:00": 40.937400817871094,
      "2024-05-28T16:30:00+00:00": 40.79999923706055,
      "2024-05-28T17:30:00+00:00": 40.5974006652832,
      "2024-05-28T18:30:00+00:00": 40.529998779296875,
      "2024-05-28T19:30:00+00:00": 40.439998626708984
    },
    "sentiment": 0.8725749254226685
  },
  {
    "title": "Bank of America\u2019s \u2018triple momentum\u2019 screeners finds stocks including Nvidia, J.P.Morgan",
    "published": 1716889800,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 41.220001220703125,
      "2024-05-28T14:30:00+00:00": 40.898799896240234,
      "2024-05-28T15:30:00+00:00": 40.937400817871094,
      "2024-05-28T16:30:00+00:00": 40.79999923706055,
      "2024-05-28T17:30:00+00:00": 40.5974006652832,
      "2024-05-28T18:30:00+00:00": 40.529998779296875,
      "2024-05-28T19:30:00+00:00": 40.439998626708984
    },
    "sentiment": 0.7072553038597107
  },
  {
    "title": "Bristol Myers licenses second compound from Prothena",
    "published": 1716866820,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 41.220001220703125,
      "2024-05-28T14:30:00+00:00": 40.898799896240234,
      "2024-05-28T15:30:00+00:00": 40.937400817871094,
      "2024-05-28T16:30:00+00:00": 40.79999923706055,
      "2024-05-28T17:30:00+00:00": 40.5974006652832,
      "2024-05-28T18:30:00+00:00": 40.529998779296875,
      "2024-05-28T19:30:00+00:00": 40.439998626708984
    },
    "sentiment": 0.7815749645233154
  },
  {
    "title": "Bristol Myers Squibb Named Top Dividend Stock With Insider Buying and 5.82% Yield (BMY)",
    "published": 1716858900,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 41.220001220703125,
      "2024-05-28T14:30:00+00:00": 40.898799896240234,
      "2024-05-28T15:30:00+00:00": 40.937400817871094,
      "2024-05-28T16:30:00+00:00": 40.79999923706055,
      "2024-05-28T17:30:00+00:00": 40.5974006652832,
      "2024-05-28T18:30:00+00:00": 40.529998779296875,
      "2024-05-28T19:30:00+00:00": 40.439998626708984
    },
    "sentiment": 0.6060868501663208
  },
  {
    "title": "3 Blue-Chip Stocks to Buy at 52-Week Lows in May",
    "published": 1716804780,
    "day_prices": {},
    "sentiment": 0.8905453085899353
  },
  {
    "title": "Bristol Myers: presents over 130 studies at ASCO",
    "published": 1716792984,
    "day_prices": {},
    "sentiment": 0.920741617679596
  },
  {
    "title": "Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo",
    "published": 1716629100,
    "day_prices": {},
    "sentiment": 0.9204940795898438
  },
  {
    "title": "S&P 500 Earnings Dashboard 24Q1 - Saturday, May 25",
    "published": 1716604200,
    "day_prices": {},
    "sentiment": 0.7771466374397278
  },
  {
    "title": "Retail Earnings & Consumer Spending: A Closer Look",
    "published": 1716549960,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 41.40999984741211,
      "2024-05-24T14:30:00+00:00": 41.290000915527344,
      "2024-05-24T15:30:00+00:00": 41.334598541259766,
      "2024-05-24T16:30:00+00:00": 41.45500183105469,
      "2024-05-24T17:30:00+00:00": 41.57500076293945,
      "2024-05-24T18:30:00+00:00": 41.29499816894531,
      "2024-05-24T19:30:00+00:00": 41.224998474121094
    },
    "sentiment": 0.8988534212112427
  },
  {
    "title": "Catalyst Watch: Costco earnings, M&A drama, Viking ratings, and a key inflation read",
    "published": 1716516240,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 41.40999984741211,
      "2024-05-24T14:30:00+00:00": 41.290000915527344,
      "2024-05-24T15:30:00+00:00": 41.334598541259766,
      "2024-05-24T16:30:00+00:00": 41.45500183105469,
      "2024-05-24T17:30:00+00:00": 41.57500076293945,
      "2024-05-24T18:30:00+00:00": 41.29499816894531,
      "2024-05-24T19:30:00+00:00": 41.224998474121094
    },
    "sentiment": 0.9077320694923401
  }
]